ISRG reported Q2 earnings and revenue that beat analyst estimates, but shares fell after hours as procedure growth slowed sequentially. The article notes strong placements were insufficient to offset the deceleration in procedural growth, driving a cautious market reaction.
ISRG reported Q2 earnings and revenue that beat analyst estimates, but shares fell after hours as procedure growth slowed sequentially. The article notes strong placements were insufficient to offset the deceleration in procedural growth, driving a cautious market reaction.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
mildly negative
Sentiment Score
-0.15
Ticker Sentiment
